Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 18
Review
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,686 | Dovepress* | 8,821+ | 285 | 9,106 | |
| PubMed Central* | 865 | 145 | 1,010 | ||
| Totals | 9,686 | 430 | 10,116 | ||
| *Since 2 June 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar